Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Good point. So you are saying for the SP to improve, ADXS only needs to get a drug approved. Sounds easy enough based on their prior experience.

Also something interesting to note. Our largest holder (Adage) also held a large stake in PBYI when they went to $230. They held during the entire drop never once adding or selling, until Q2 2017 when they sold 30% of their stake in PBYI in the $80 range followed by a recent filing where they liquidated another 850k shares just 10 days ago, right around $100 SP. Even the pros make mistakes. Adage missed out on a $1B+ payday, and is settling for a price 60% below its 230 highs.